| Lymphangioleiomyomatosis, a Study on Cathepsin K (NCT05323370) | University Hospital, Tours | 2022-05-31 |
| Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy (NCT05604170) | Marinus Pharmaceuticals | 2022-05-16 |
| Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy (NCT05323734) | Marinus Pharmaceuticals | 2022-04-01 |
| Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC (NCT05059327) | Noema Pharma AG | 2022-03-03 |
| Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study (NCT05104983) | Darcy Krueger | 2021-10-13 |
| Acceptance and Commitment Therapy in Tuberous Sclerosis Complex (NCT05867576) | University Hospitals Bristol and Weston NHS Foundation Trust | 2021-08-12 |
| Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution (NCT05044819) | Jazz Pharmaceuticals | 2021-07-07 |
| Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants (NCT04987463) | Katarzyna Kotulska | 2021-05-07 |
| Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants (NCT04595513) | Children's Hospital Medical Center, Cincinnati | 2020-09-08 |
| The Effectiveness and Safety of Vagus Nerve Stimulation for TRE (NCT04198207) | Beijing Children's Hospital | 2019-12-10 |
| Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation Relationship (NCT04112537) | University Hospital, Montpellier | 2019-03-01 |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex (NCT03356769) | Peking Union Medical College Hospital | 2017-11-20 |
| Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment (NCT02962414) | Novartis Pharmaceuticals | 2017-06-08 |
| Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (NCT02849457) | Martina Bebin | 2016-12-01 |
| An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) (NCT02544750) | Jazz Pharmaceuticals | 2016-08-31 |
| Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex (NCT06789419) | Beijing Children's Hospital | 2016-07-01 |
| Studies in Patients With Tuberous Sclerosis Complex (NCT03276195) | Translational Genomics Research Institute | 2016-05-01 |
| Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex (NCT02687633) | University of California, Los Angeles | 2015-09-01 |
| Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France (NCT02887781) | University Hospital, Brest | 2015-08-13 |
| The Cognitive Variability in NF1 and TSC Monozygotic Twins (NCT02436746) | Erasmus Medical Center | 2015-04-01 |
| Everolimus for Cancer With TSC1 or TSC2 Mutation (NCT02201212) | Dana-Farber Cancer Institute | 2014-09-01 |
| Safety of Simvastatin in LAM and TSC (NCT02061397) | University of Pennsylvania | 2014-03-01 |
| A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD (NCT02451696) | NYU Langone Health | 2014-01-01 |
| Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex (NCT02098759) | Sergiusz Jozwiak | 2013-11-01 |
| Rapalogues for Autism Phenotype in TSC: A Feasibility Study (NCT01929642) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2013-07-01 |
| Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC) (NCT01780441) | Boston Children's Hospital | 2013-01-01 |
| Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex (NCT01730209) | Erasmus Medical Center | 2012-11-01 |
| Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC (NCT01767779) | University of Alabama at Birmingham | 2012-09-01 |
| Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) (NCT01289912) | Mustafa Sahin | 2011-01-01 |
| Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) (NCT01070316) | Children's Hospital Medical Center, Cincinnati | 2010-01-01 |
| Tuberous Sclerosis Complex Natural History Study: Renal Manifestations (NCT00598455) | Children's Hospital Medical Center, Cincinnati | 2008-02-01 |